Cargando…
COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation
The development of a vaccine for COVID-19 presented hope for a way out of the global crisis caused by the virus. However, a potential barrier may be vaccine hesitancy, and identifying the factors that affect it is critical, especially concerning a new vaccine technology. The purpose of this research...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235256/ https://www.ncbi.nlm.nih.gov/pubmed/35782475 |
_version_ | 1784736275947847680 |
---|---|
author | Teitler-Regev, Sharon Hon-Snir, Shlomit |
author_facet | Teitler-Regev, Sharon Hon-Snir, Shlomit |
author_sort | Teitler-Regev, Sharon |
collection | PubMed |
description | The development of a vaccine for COVID-19 presented hope for a way out of the global crisis caused by the virus. However, a potential barrier may be vaccine hesitancy, and identifying the factors that affect it is critical, especially concerning a new vaccine technology. The purpose of this research is to identify the factors that effects vaccine hesitancy by using a holistic view. The data were collected from 504 people in December 2020, 3 days before the vaccine operation started in Israel. The analysis included three categories of determinants: (1) contextual influences; (2) health records; and (3) perceived health attitudes. The results indicate that different sets of variables affect willingness to accept the vaccine among the whole spectrum of the vaccine-hesitant and the undecided subsample. In the full sample, gender, age, income, influenza vaccine, perceived trust, perceived susceptibility, perceived benefits, and perceived barriers affected vaccine acceptance. The perceived level of suffering from COVID-19 was associated with willingness to vaccinate, and when religious beliefs increased, the intention to vaccinate decreased. For the undecided subsample, the factors included gender, influenza vaccine, trust in the vaccine company, and perceived vaccine benefits and barriers. The results suggest that efforts of governments and health institutions should focus on women and highlight the vaccine as an opportunity to “go back to normal” without worries. Those results will help implement vaccine strategy in the following cases: if infant vaccination is pursued and if emergency vaccines or new vaccine technologies emerge for another pandemic as well. |
format | Online Article Text |
id | pubmed-9235256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | YJBM |
record_format | MEDLINE/PubMed |
spelling | pubmed-92352562022-06-30 COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation Teitler-Regev, Sharon Hon-Snir, Shlomit Yale J Biol Med Original Contribution The development of a vaccine for COVID-19 presented hope for a way out of the global crisis caused by the virus. However, a potential barrier may be vaccine hesitancy, and identifying the factors that affect it is critical, especially concerning a new vaccine technology. The purpose of this research is to identify the factors that effects vaccine hesitancy by using a holistic view. The data were collected from 504 people in December 2020, 3 days before the vaccine operation started in Israel. The analysis included three categories of determinants: (1) contextual influences; (2) health records; and (3) perceived health attitudes. The results indicate that different sets of variables affect willingness to accept the vaccine among the whole spectrum of the vaccine-hesitant and the undecided subsample. In the full sample, gender, age, income, influenza vaccine, perceived trust, perceived susceptibility, perceived benefits, and perceived barriers affected vaccine acceptance. The perceived level of suffering from COVID-19 was associated with willingness to vaccinate, and when religious beliefs increased, the intention to vaccinate decreased. For the undecided subsample, the factors included gender, influenza vaccine, trust in the vaccine company, and perceived vaccine benefits and barriers. The results suggest that efforts of governments and health institutions should focus on women and highlight the vaccine as an opportunity to “go back to normal” without worries. Those results will help implement vaccine strategy in the following cases: if infant vaccination is pursued and if emergency vaccines or new vaccine technologies emerge for another pandemic as well. YJBM 2022-06-30 /pmc/articles/PMC9235256/ /pubmed/35782475 Text en Copyright ©2022, Yale Journal of Biology and Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons CC BY-NC license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes. |
spellingShingle | Original Contribution Teitler-Regev, Sharon Hon-Snir, Shlomit COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine Operation |
title | COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine
Operation |
title_full | COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine
Operation |
title_fullStr | COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine
Operation |
title_full_unstemmed | COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine
Operation |
title_short | COVID-19 Vaccine Hesitancy in Israel Immediately Before the Vaccine
Operation |
title_sort | covid-19 vaccine hesitancy in israel immediately before the vaccine
operation |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235256/ https://www.ncbi.nlm.nih.gov/pubmed/35782475 |
work_keys_str_mv | AT teitlerregevsharon covid19vaccinehesitancyinisraelimmediatelybeforethevaccineoperation AT honsnirshlomit covid19vaccinehesitancyinisraelimmediatelybeforethevaccineoperation |